🇺🇸 FDA
Pipeline program

Nitazoxanide Tablets

NITFQM0320OR

Unknown small_molecule completed

Quick answer

Nitazoxanide Tablets for COVID-19 is a Unknown program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
COVID-19
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials